These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1195 related items for PubMed ID: 16640529

  • 1. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM.
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [Abstract] [Full Text] [Related]

  • 3. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of results at a single center].
    Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P.
    Dtsch Med Wochenschr; 2006 Oct 20; 131(42):2327-32. PubMed ID: 17043982
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH.
    Liver Transpl; 2007 Sep 20; 13(9):1236-45. PubMed ID: 17763401
    [Abstract] [Full Text] [Related]

  • 5. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.
    Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J.
    Hepatology; 2001 Jan 20; 33(1):22-7. PubMed ID: 11124816
    [Abstract] [Full Text] [Related]

  • 6. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.
    Sanchez EQ, Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, Watkins DL, Weinstein JS, Murray NG, Byers D, Christensen LL, Klintmalm GB.
    Transplantation; 2003 Dec 15; 76(11):1583-8. PubMed ID: 14702528
    [Abstract] [Full Text] [Related]

  • 7. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of 52 patients in QLTS].
    Xu CE, Lynch SV, Balderson GA, Fawcett J, Strong RW, Yeong S.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep 15; 12(9):543-5. PubMed ID: 15387907
    [Abstract] [Full Text] [Related]

  • 8. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal.
    Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I.
    Transplant Proc; 2009 Jun 15; 41(5):1707-12. PubMed ID: 19545712
    [Abstract] [Full Text] [Related]

  • 10. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation.
    Levitsky J, Hart J, Cohen SM, Te HS.
    Liver Transpl; 2003 Jul 15; 9(7):733-6. PubMed ID: 12827561
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study.
    Khettry U, Anand N, Faul PN, Lewis WD, Pomfret EA, Pomposelli J, Jenkins RL, Gordon FD.
    Liver Transpl; 2003 Jan 15; 9(1):87-96. PubMed ID: 12514778
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 13. Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?
    Jacob DA, Bahra M, Schmidt SC, Schumacher G, Weimann A, Neuhaus P, Neumann UP.
    Ann Transplant; 2008 Jan 27; 13(3):35-42. PubMed ID: 18806733
    [Abstract] [Full Text] [Related]

  • 14. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec 27; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 15. Caroli's disease and orthotopic liver transplantation.
    Habib S, Shakil O, Couto OF, Demetris AJ, Fung JJ, Marcos A, Chopra K.
    Liver Transpl; 2006 Mar 27; 12(3):416-21. PubMed ID: 16498655
    [Abstract] [Full Text] [Related]

  • 16. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 17. Liver transplantation for primary biliary cirrhosis in a hepatitis endemic region: a single-center Asian experience.
    Sun CK, Chen CL, Concejero AM, Wang CC, Wang SH, Liu YW, Yang CH, Yong CC.
    Clin Transplant; 2011 Apr 27; 25(1):47-53. PubMed ID: 20560991
    [Abstract] [Full Text] [Related]

  • 18. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 19. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW.
    Semin Liver Dis; 2000 Dec 27; 20(4):481-95. PubMed ID: 11200417
    [Abstract] [Full Text] [Related]

  • 20. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 27; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 60.